Wednesday, 12 November 2014
Cineworld: The O2, London, SE10 0DX, UK
www.regonline.co.uk/innatethera2014
The identification of antigen recognition receptors for innate immunity has sparked great interest in therapeutic manipulation of the innate immune system. For example Toll-like receptor agonists are being developed for the treatment of cancer, allergies and viral infections, and as adjuvants for cancer and disease vaccines. This event will explore current research and applications of the innate system for therapeutic applications. There will be plenty of opportunity for discussion and debate and we encourage submission of abstracts for both oral and poster presentation.
This event has CPD accreditation and is part of the 2014 Innate Immunity Summit www.InnateImmunitySummit2014.com
The Deadline for abstract submissions for oral presentation is July 10th 2014
Abstracts for poster presentation only can be submitted up to two weeks before the event
You can download the instructions for authors at
www.euroscicon.com/AbstractsForOralAndPosterPresentation.pdf
Talks include
Regulation of autoimmune myocarditis and inflammatory cardiomyopathy by innate immunity
Dr Przemyslaw Blyszczuk, Junior Group Leader, Cardioimmunology, University of Zurich, Switzerland
Inflammatory dilated cardiomyopathy refers to acquired cardiac dysfunction that often results from myocarditis. Infection-triggered heart-specific autoimmunity represents the most prominent cause of myocarditis. In my talk, I will present how innate immune response on various myeloid cells can promote survival of activated heart-reactive CD4+ T cells, but also can prevent uncontrolled expansion autoreactive T cells in mouse model of experimental autoimmune myocarditis. I will also present how innate signalling promotes pathological remodelling and aggravates development of typical end-stage heart failure phenotype in inflammatory dilated cardiomyopathy.
High-intensity ultra-short electric pulse applications in modulating innate immunity
Dr Sunil K. Joshi, Assistant Professor of Cellular Immunology School of Medical Diagnostic and Translational Sciences, Frank Reidy Research Center for Bioelectrics, Old Dominion University,Virginia, USA
M1/M2 Macrophages: A Copernican Revelation in Immunology
Dr Charles Mills, BioMedical Consultants, United States
www.regonline.co.uk/innatethera2014
